RxDoctor Payments Data

Belachew Tessema, MD

Otolaryngology · Farmington, CTNPI 1417005000

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $36,160 of the $45,008 with a category attached, or 80.3%. Sanofi accounts for 82.1% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $42,536, more than ten times the $518 reported in 2019. Among otolaryngology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,008in general payments, 2019–2025

Across 93 payments — averaging $483.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$37K
  • Regeneron Healthcare Solutions, Inc.$7K
  • Intersect ENT, Inc.$368
  • Medtronic$174
  • GSK$144
  • Acclarent, Inc$142
  • plus $341 from 6 others

What the payments were for

  • Consulting fees$2,6486%
  • Speaking & faculty fees$36,16080%
  • Travel & lodging$3,5778%
  • Food & beverage$2,5506%
  • Education$730%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,008 in reported general payments places this provider in the 95th percentile of 119 otolaryngology providers in Connecticut.

See all otolaryngology providers in Connecticut

Medicare billing

Part B allowed, 2024
$108,483
Medicare patients
174
Services billed
507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab25$93,551
Dupixent SyringeDupilumab11$41,162
Budesonide21$2,648
Ipratropium Bromide67$2,507
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav50$580
Doxycycline Monohydrate22$458
Fluticasone Propionate22$291
Omeprazole16$242
Methylprednisolone27$207
Prednisone52$169
Doxycycline Hyclate11$95
Famotidine17$80
Azithromycin16$43

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Farmington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →